In Vivo Plasma Lipid Oxidation in Sugar-Induced Rat Hypertriglyceridemia and Hypertension

Hypertension

Volumn 30, Issue 3, 1997, Pages 624-628

  Hafidi, Mohammed El ^a   Banos, Guadalupe ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; ESTROGEN; FATTY ACID; FERRIC ION; FERROUS ION; FREE RADICAL; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; IRON; IRON DEXTRAN; LINOLEIC ACID; LINOLENIC ACID; LIPID; LIPOPROTEIN; MALONALDEHYDE; OLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; POLYUNSATURATED FATTY ACID; REACTIVE OXYGEN METABOLITE; STEARIC ACID; SUGAR; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FLUORESCENCE; GAS CHROMATOGRAPHY; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPID COMPOSITION; LIPID OXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; DIETARY SUCROSE; FATTY ACIDS; FEMALE; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPID PEROXIDATION; MALE; RATS; RATS, WISTAR; SEX FACTORS;

EID: 0342617821     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.hyp.30.3.624     Document Type: Article

References (28)

1. Yagi K. Lipid peroxides in human diseases. Chem Phys Lipids. 1987;45:337-351.
2. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
3. Haffners SM, Mykkanen L, Valdes RA. LDL size and subclass pattern in biethnic population. Artherioscler Thromb. 1993;13:1623-1630.
4. de Graaf J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendriks JCM, Stalenhoef AFH. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfractions in healthy subjects. Arterioscler Thromb. 1991;11:298-306.
5. Tribble DL, Holl LG, Wood PD. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis. 1992;93:189-199.
6. Yla-Herttwala S, Palinski W, Rosenfeld ME. Evidence for the presence of oxidability in atherosclerosis lesions of rabbit and man. J Clin Invest. 1989;84:186-1989.
7. Salonen JT, Yla-herttwala S, Yamamoto R. Autoantibody against oxidized low lipoprotein and progression of carotid atherosclerosis. Lancet. 1992;339:883-887.
8. Kita T, Nagano Y, Yakod M. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci U S A. 1987;84:5928-5931.
9. Stampfer MJ, Hennekens CH, Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
10. Rimm EB, Stampfer MJ, Asherio A. Vitamin E and the risk of coronary disease in men. N Engl J Med. 1993;328:1450-1459.
11. Hazzar W. Aging, lipoprotein metabolism and atherosclerosis: a clinical conundrum. In: Bates S, Gangloff E, eds. Atherogenesis and Aging. New York, NY: Springer-Verlag; 1987:75-703.
12. Bush TL, Miller SR, Criqui MH. Risk factors for morbidity and mortality in older populations: an epidemiologic approach. In: Hazzard WR, Anders R, Bierman EL, eds. Principle of Geriatric Medicine and Gerontology. New York, NY: McGraw-Hill; 1990:125-137.
13. Eriksson M, Berglund L, Rudling M. Effect of estrogens on low density lipoprotein metabolism in males. J Clin Invest. 1989;84:802-810.
14. Kushwaha R, Foster D, Barett B. Effect of estrogens and progesterone on metabolism on apoprotein B in baboons. Am J Physiol. 1990;258:E172-E183.
15. Mooradian AD. Antioxidant properties of steroids. J Steroids Biochem Mol Biol. 1993;45:509-511.
16. Wiseman H, Quin P. The antioxidant action of synthetic oestrogens involves a decrease in membrane fluidity: relevence to their potential use as anticancer and cardioprotective agents compared to tamoxifen? Free Radic Res. 1994;21:187-194.
17. Sugioka K, Shimosegawa Y, Nakano M. Estrogens as a natural antioxidant of membrane phospholipids peroxidation. FEBS Lett. 1987;210:37-39.
18. Lacrot M, Leal AM, Liza M, Martin C, Martinez R, Ruiz-Larrea MB. Protective effect of estrogens and catecholestrogens against peroxidative membrane damage in vitro. Lipids. 1995;30:141-146.
19. Girotti AW. Mechanism of lipid peroxidation. Free Radic Biol Med. 1985;1:87-95.
20. Fraga CG, Leibovitz GL, Tappel AL. Halogenated compounds as initiators of lipid peroxidation in tissue slices. Free Radic Biol Med. 1987;3:119-123.
21. Folch L, Lees M, Sloane-Stanley CH. A simple method for the isolation and a purification of total lipid from animal tissues. J Biol Chem. 1957;226:497-509.
22. Mutane J, Mitjavila MT, Per Puic-Parellada R, Fernandez Y, Mitjavila S. Dietary lipid and iron status modulate lipid peroxidation in rats with adjuvant arthritis. J Nutr. 1995;125:1930-1937.
23. Reaven GM, Risser TR, Ida Chen Y-D, Reaven EP. Characterization of a model of dietary-induced hypertriglyceridemia in young nonobese rats. J Lipid Res. 1979;20:371-378.
24. Bernal CA, Gutman RA, Lombardo YB. The duration of feeding on a sucrose-rich diet determines variable in vitro effects of insulin and fructose on rat liver triglyceride metabolism. J Nutr Biochem. 1995;6:422-430.
25. Hulman S, Falkner B. The effect of excess dietary sucrose on growth, blood pressure, and metabolism in developing Sprague-Dawley rats. Pediatr Res. 1994;36:95-101.
26. Grekin RJ, Vollmer AP, Sider RS. Pressor effect of portal venous oleate infusion: a proposed mechanism for obesity hypertension. Hypertension. 1995;26:193-198.
27. Singer P, Voigt S, Godicke W. Inverse relationship between linoleic acid in serum and in adipose tissue of patients with essential hypertension. Prostaglandins Leukot Med. 1982;9:603-613.
28. Hoffmann P. Cardiovascular actions of dietary polyunsaturates and related mechanisms. Prostaglandins Leukot Med. 1986;21:113-147.